PS-C28-1: EARLY DETECTION OF DEMENTIA AT COMMUNITY PHARMACIES USING SIMPLE TOUCH PANEL SCREENING CHECK
PS-C28-1: EARLY DETECTION OF DEMENTIA AT COMMUNITY PHARMACIES USING SIMPLE TOUCH PANEL SCREENING CHECK
复制标题
PS-C28-1：使用简单的触摸屏筛查检查在社区药房早期检测痴呆症
DOI：
10.1097/01.hjh.0000917548.39038.da
复制
发表时间：
2023
影响因子：
4.9
通讯作者：
Egawa Takashi
中科院分区：
文献类型：
--
作者：
Kai Mamiko;Tominaga Koji;Morita Kazutoshi;Soda Yoshio;Sejima Ei;Dendo Hitomi;Yamaguchi Ryosuke;Takada Makiko;Akura Hiroshi;Ono Kazuhiko;Hayashi Toshinobu;Iida Hitoshi;Ogomori Koji;Kawasaski Hiroaki;Egawa Takashi
目的：本研究的目的是检验简单的触摸屏痴呆症筛查检查 (TPCD) 是否能有效地在社区药房早期发现痴呆症。 设计和方法：这是一项针对前往大学医院附近的药房（项目 1）或全科医师诊所（项目 2）的成年访客的前瞻性研究。参与者是在药房自愿招募的，并在书面知情同意后进行登记。为了评估参与者的认知功能，我们使用健忘咨询程序 MSP-1100（Nihon Kohden，东京）对单词的即时记忆和近期记忆、时间定向、图形识别进行了评分。当分数为或低于12分（满分15分）时，参与者被怀疑患有痴呆症，并建议前往大学医院的精神科门诊（项目1）或去看全科医师（项目2）。下次访问药房时，参与者被询问是否接受过精神科专家的咨询。 结果：[项目1] TPCD于2019年1月至2020年1月对81人（35名男性）进行了治疗。其中一人因协议撤销而被排除，另一人因已在另一家诊所接受痴呆症治疗而被排除。在 79 名参与者中，17 人（21.5%，8 名男性）被怀疑患有痴呆症，并被建议去精神科诊所就诊。两名参与者拜访了精神科专家，并被诊断为患有轻度认知障碍。四人咨询了他们的家庭医生，但尚未去精神科诊所。 11人拒绝咨询。[项目2]目前，从2021年1月至2022年4月，对30人（8名男性）进行了TPCD，其中10名（33.3%，3名男性）疑似患有痴呆症。目前招募正在进行中。结论：初步分析表明，药店的TPCD可能对早期发现痴呆症有效。要加强通行证支持精神科专家会诊就诊。
Objective:The purpose of this study was to examine whether a simple touch panel screening check for dementia (TPCD) would be effective for early detection of dementia at community pharmacies.Design and Methods:This was a prospective study of adult visitors presenting to a pharmacy adjacent to a university hospital (Project 1) or to a general physician clinic (Project 2). Participants were voluntarily recruited in the pharmacies and were registered after written informed consent. To evaluate the cognitive function of participants, we scored immediate and recent memories of words, time orientation, figure recognition using a Forgetfulness Consultation Program MSP-1100 (Nihon Kohden, Tokyo). When the score was or less than 12 out of 15 points, participants were suspected as having dementia and recommended to visit the psychiatric outpatient clinic of the university hospital (Project 1) or to visit the general physician (Project 2). On the next visit to the pharmacy, the participants were asked whether they had received the consultation of the psychiatric specialists.Results:[Project 1] TPCD was conducted on 81 individuals (35 men) from January 2019 to January 2020. One was excluded because of agreement withdrawal and another was excluded because he had already been treated for dementia at another clinic. Of 79 participants, 17 (21.5%, 8 men) were suspected as having dementia and were recommended to visit the psychiatric clinic. Two participant visited psychiatric specialists and were diagnosed as having mild cognitive impairment. Four consulted with their family physicians but have not yet visit the psychiatric clinic. Eleven refused the consultation.[Project 2] Currently, TPCD was conducted on 30 individuals (8 men) and 10 (33.3%, 3 men) were suspected to having dementia from January 2021 to April 2022. The recruitment is now ongoing.Conclusion:This preliminary analysis suggests that TPCD in pharmacies may be effective for early detection of dementia. It is necessary to strengthen the pass to support the consultation visit to psychiatric specialists.